Overview: CSPC Pharmaceutical Group Limited is an investment holding company involved in the research, development, manufacture, and sale of pharmaceutical products across China and ...

Overview: CSPC Pharmaceutical Group Limited is an investment holding company involved in the research, development, manufacture, and sale of pharmaceutical products across China and internationally, ...

This advancement positions CSPC as a significant player in addressing unmet medical needs in the oncology sector. For further insights into HK:1093 stock, check out TipRanks’ Stock Analysis page.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

China National Offshore Oil Corporation (CNOOC) and Shell plc's joint venture, CNOOC and Shell Petrochemicals Company Limited (CSPC), announced Wednesday they would invest in the Huizhou Phase III ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

AstraZeneca has joined the ranks of pharma companies seeking to bring drugs targeting lipoprotein(a) to market, paying $100 million upfront for rights to a drug developed by CSPC Pharmaceutical.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

AI-powered stock picks with a proven track record to beat the S&P 500.

CSPC Pharmaceutical Group Ltd. on Jan. 13 gained the National Medical Products Administration’s approval of Shanzeping (prusogliptin tablets; DBPR-108) as a novel oral dipeptidyl peptidase-IV (DPP-4) ...